Card image cap

Sherrod Brown's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. Senate (OH) - Sr

1

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 4
Date Title
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
04/19/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Senator Markey Leads Colleagues in Urging Fda to Ban Menthol Cigarettes
04/16/2021 Letter to the Hon. Xavier Becerra, Secretary of Health and Human Services - Feinstein, Markey, Colleagues Urge FDA to Ban Menthol Cigarettes
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/04/2021 Letter to Dr. Nora D. Volkow, Director of The National Institute on Drug Abuse - Brown, Capito Lead Letter Supporting Enhanced Research and Development of Methamphetamine Treatment Options
09/15/2020 Letter to Mr. Stephen J. Ubl, President and CEO of PhRMA - Senators Demand Big Pharma Allow Low-income Patients to Access Lifesaving, Discounted 340B Drugs and Care
05/22/2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
10/29/2019 Letter to the Hon. Alex Azar II, Secretary of the U.S. Department of Health and Human Services - Amid Delay, Senator Kaine Urges Trump Administration to Prioritize Children's Health and Keep Promise to Ban Flavored E-Cigarettes
10/11/2019 Letter to K.C. Crosthwaite, CEO of Juul - Senator Hassan, Colleagues Call on Juul to End Unfair Forced Arbitration Agreements That Restrict Americans' Access to Justice
10/29/2018 Letter to the Hon. Scott Gottlieb, Comissioner of the Food and Drug Administration - Wyden, Durbin, Murray & Colleagues Urge FDA to Protect Kids from Tobacco Use and Addiction
07/06/2018 Letter to the Centers for Disease Control and Prevention - Senators Call on CDC to better Support Forensic Medicine as Overdose Deaths Continue to Rise
05/30/2018 Letter to the Honorable Gene L. Dodaro, Comptroller General for the U.S. Government Accountability Office - Senator Markey Leads Bipartisan Call for Assessment of Drug Treatment Availability and Effectiveness in Correctional Facilities
04/18/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
03/08/2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
03/05/2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
03/02/2018 Letter to Aetna, AHIP, Anthem, BCBS, CareSource, Centene, Cigna, Humana, Kaiser, Molina, and UnitedHealth - Step Up Response to Opioid Epidemic
03/01/2018 Letter to Bruce D. Broussard, Chief Executive Officer & President of Humana - Feinstein, Brown, Markey Ask Health Insurers to Step Up Response to Opioid Epidemic
01/19/2018 Letter to Donald Trump, President of the United States - The Opioid Crisis is too Important for You to Over-Promise and Under-Deliver
01/17/2018 Letter to President Donald Trump - Blumenthal, Colleagues Call on President Trump to Nominate Strong, Experienced Leadership to Key Drug Policy Positions
01/12/2018 Letter to Donald Trump, President - Renew the Opioid Public Health Emergency
Page 1 of 4
arrow_upward